Nomura Holdings’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-14,200
| Closed | -$306K | – | 1694 |
|
|
2025
Q4 | $357K | Sell |
14,200
-22,400
| -61% | -$526K | ﹤0.01% | 1627 |
|
|
2025
Q3 | $828K | Buy |
+36,600
| New | +$854K | ﹤0.01% | 1453 |
|
|
2025
Q1 | – | Sell |
-7,000
| Closed | -$223K | – | 1758 |
|
|
2024
Q4 | $223K | Buy |
+7,000
| New | +$211K | ﹤0.01% | 2032 |
|
|
2024
Q1 | – | Sell |
-14,695
| Closed | -$880K | – | 1604 |
|
|
2023
Q4 | $880K | Buy |
+14,695
| New | +$745K | ﹤0.01% | 1213 |
|
|
2023
Q3 | – | Sell |
-31,186
| Closed | -$2.84M | – | 1366 |
|
|
2023
Q2 | $2.84M | Buy |
+31,186
| New | +$2.69M | 0.01% | 640 |
|
|
2023
Q1 | – | Sell |
-59,465
| Closed | -$3.07M | – | 1434 |
|
|
2022
Q4 | $3.07M | Buy |
59,465
+3,295
| +6% | +$175K | 0.01% | 620 |
|
|
2022
Q3 | $3.83M | Buy |
+56,170
| New | +$3.32M | 0.02% | 633 |
|
|
2022
Q2 | – | Sell |
-104,067
| Closed | -$5.72M | – | 1800 |
|
|
2022
Q1 | $5.72M | Buy |
104,067
+90,576
| +671% | +$4M | 0.02% | 574 |
|
|
2021
Q4 | $640K | Sell |
13,491
-271,009
| -95% | -$10.7M | ﹤0.01% | 1353 |
|
|
2021
Q3 | $9.56M | Buy |
284,500
+238,000
| +512% | +$13.4M | 0.02% | 423 |
|
|
2021
Q2 | $2.94M | Buy |
46,500
+32,500
| +232% | +$1.68M | 0.01% | 739 |
|
|
2021
Q1 | $600K | Sell |
14,000
-7,300
| -34% | -$345K | ﹤0.01% | 1285 |
|
|
2020
Q4 | $1.22M | Buy |
+21,300
| New | +$901K | ﹤0.01% | 973 |
|
|
2020
Q3 | – | Sell |
-8,500
| Closed | -$277K | – | 1300 |
|
|
2020
Q2 | $277K | Sell |
8,500
-145,500
| -94% | -$4.67M | ﹤0.01% | 961 |
|
|
2020
Q1 | $4.13M | Buy |
+154,000
| New | +$5.47M | 0.02% | 351 |
|
|
2019
Q4 | – | Sell |
-16,000
| Closed | -$355K | – | 1094 |
|
|
2019
Q3 | $355K | Buy |
+16,000
| New | +$440K | ﹤0.01% | 1007 |
|
Other funds holding APLS
Nomura Holdings's APLS Position: Q1 2026 in Review
Nomura Holdings sold out of Apellis Pharmaceuticals (APLS) in Q1 2026, closing a stake of 14,200 shares — an estimated $306K sold.
Nomura Holdings first reported a position in APLS in Q3 2019 and held it in 16 quarters. The position peaked at $9.56M in Q3 2021. 323 funds tracked by Wall St. Rank hold APLS as of Q1 2026.
- Nomura Holdings reported no remaining Apellis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Nomura Holdings sold 14,200 Apellis Pharmaceuticals shares in Q1 2026, an estimated $306K.
- Nomura Holdings first reported a position in Apellis Pharmaceuticals in Q3 2019 and held it in 16 quarters.
- Nomura Holdings's Apellis Pharmaceuticals position peaked at $9.56M in Q3 2021.
- 323 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.